A blood sugar monitor without finger pricks is a continuous glucose monitor, or CGM — a small sensor worn on the upper arm or abdomen that reads glucose from interstitial fluid every 1-5 minutes and sends the data to a phone or receiver. CGMs have replaced most daily fingersticks for people with diabetes on insulin, and over-the-counter versions now extend that convenience to people with prediabetes or general metabolic interest. No FDA-cleared device measures blood glucose fully noninvasively, despite aggressive marketing from some smartwatch brands.
How No-Prick Blood Sugar Monitors Work
All FDA-cleared CGMs use a thin, flexible filament (thinner than a human hair) inserted just under the skin. The filament sits in interstitial fluid — the thin layer of liquid surrounding body cells — and reacts with a glucose-oxidase enzyme. That reaction generates a tiny electrical signal that correlates with glucose concentration. The sensor sends a reading by Bluetooth to your phone every 1 minute (Stelo), every 1 minute (FreeStyle Libre 3 Plus), or every 5 minutes (Dexcom G7).
Because glucose travels from blood into interstitial fluid with a small lag, CGM readings trail fingerstick values by 5-15 minutes during rapid changes. This lag is normal and does not affect clinical use when trends are stable. For fast-changing situations (after a high-carb meal, during exercise, after a correction insulin dose), a confirmatory fingerstick may still be warranted.
Prescription CGMs vs. Over-the-Counter CGMs
Until 2024, every CGM in the U.S. required a prescription. The FDA then cleared Stelo (by Dexcom) and later Lingo (by Abbott) as over-the-counter biosensors for adults 18 and older not using insulin. This opened the door for people with prediabetes to wear a CGM without navigating insurance.
| Device | Rx or OTC | Wear Time | MARD | Approved Use |
|---|---|---|---|---|
| Dexcom G7 10-day | Prescription | 10 days | ~8.2% | Diabetes, ages 2+ |
| Dexcom G7 15-day | Prescription | 15 days | ~8.0% | Diabetes, ages 18+ |
| FreeStyle Libre 3 Plus | Prescription | 15 days | ~8.2% | Diabetes, ages 2+ |
| Stelo (Dexcom) | OTC | 15 days | ~9.0% | Adults not on insulin |
| Lingo (Abbott) | OTC | 14 days | ~9-10% | Adults, wellness use |
Dexcom G7: Best-in-Class Prescription CGM
The Dexcom G7 is a one-piece disc roughly the size of three stacked quarters, worn on the back of the upper arm. It sends glucose data every 5 minutes and is compatible with the Tandem t:slim X2 and Omnipod 5 automated insulin delivery systems. A 15-day version was FDA-cleared in 2025 for adults only; children continue on the 10-day sensor.
Users pair the G7 with iOS or Android phones or an optional receiver. Alerts can warn of impending lows as much as 20 minutes before they occur — a major safety advantage for insulin users.
FreeStyle Libre 3 Plus: Longest-Wear Prescription Option
Abbott’s FreeStyle Libre 3 Plus is the smallest CGM on the U.S. market, about the size of two stacked pennies. It streams glucose every minute via Bluetooth to the LibreLink app. Wear time is 15 days, and the sensor is FDA-cleared for adults and children age 2 and older. It is compatible with the Tandem t:slim X2 Control-IQ Plus algorithm but not yet with Omnipod 5.
Stelo: Over-the-Counter Pick for Prediabetes
Stelo is the first FDA-cleared over-the-counter CGM in the United States. It uses the same sensor chemistry as the Dexcom G7 but is tuned for non-insulin users. Stelo does not have urgent low alarms because it is not intended for people at risk of severe hypoglycemia. It is available directly through Dexcom’s website and select retailers, priced around $99 per month for two sensors (each 15-day wear).
Stelo is a natural fit for anyone newly diagnosed with prediabetes who wants to see how specific foods affect glucose. See our guide on reversing prediabetes for how CGM data can support lifestyle change.
Lingo: Wellness-Focused OTC CGM
Abbott’s Lingo is a 14-day over-the-counter sensor marketed primarily for metabolic wellness rather than clinical diabetes management. It reports a proprietary “Lingo Count” metric alongside glucose readings to estimate glycemic variability. Pricing starts at roughly $49 for a 2-week plan, $89 for a month, and $249 for three months.
The Truth About Noninvasive Glucose Watches and Rings
The FDA has issued multiple public warnings stating that no smartwatch or smart ring currently on the market is capable of measuring blood glucose noninvasively. Any product advertising this capability is either misleading or outright fraudulent. Several research groups are pursuing optical spectroscopy, millimeter-wave, and sweat-based sensors, but no such technology has passed FDA review. If a product claims to check blood sugar from your wrist without any skin sensor, be skeptical.
Who Benefits Most From a No-Prick Monitor
- Adults on insulin: CGM is the standard of care for anyone using basal-bolus therapy or an insulin pump.
- People with hypoglycemia unawareness: Alarms can prevent dangerous lows.
- Prediabetes and early type 2 diabetes: Short-term CGM use can reveal post-meal spikes and guide dietary changes.
- Pregnant patients: CGM is increasingly used in gestational and pre-gestational diabetes.
- Caregivers: Real-time data sharing via Dexcom Follow or LibreView brings peace of mind.
Insurance and Cost Considerations
Medicare Part B covers prescription CGMs for people with diabetes on insulin or those with documented problematic hypoglycemia. Most commercial plans cover G7 and Libre 3 Plus with a prescription; copays usually range from $35 to $150 per month. OTC options like Stelo and Lingo are cash-pay and may be covered by HSA or FSA funds.
Limitations and Safety Notes
No sensor is perfect. Fingerstick confirmation is still recommended when readings do not match symptoms, during the first 24 hours of a new sensor if readings are unstable, and when acetaminophen doses exceed 1,000 mg every 6 hours (known interference with some sensors). Hydroxyurea causes falsely high readings on Dexcom sensors and is a contraindication.
Skin irritation from adhesive occurs in a minority of users. Barrier wipes, overlay patches, and site rotation help. If persistent rash or poor sensor performance continues, talk with your clinician about trying a different brand.
The Bottom Line
The only proven blood sugar monitors without finger pricks are CGMs, which still use a small under-skin filament but eliminate nearly all fingersticks. Prescription options (Dexcom G7, FreeStyle Libre 3 Plus) remain the gold standard for insulin users and people with diabetes. Over-the-counter options (Stelo, Lingo) open CGM access for people with prediabetes or wellness interest. Ignore marketing claims about watches or rings that promise noninvasive glucose tracking — those do not exist yet.
Before starting any CGM, speak with your clinician about whether it fits your monitoring plan and how the data will shape your treatment approach.
Sources
- American Diabetes Association. Standards of Care in Diabetes 2025 — Diabetes Technology.
- U.S. Food and Drug Administration. FDA clears first over-the-counter continuous glucose monitor (2024).
- Centers for Disease Control and Prevention. Continuous Glucose Monitoring.
- National Institute of Diabetes and Digestive and Kidney Diseases. Continuous Glucose Monitoring.
